PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#Scilex Pharmaceuticals ×

UPDATED
Regulatory Updates
Sep 24, 2026•1 min read
FDA Approves GLOPERBA Oral Colchicine Solution (NDA 210942)
Scilex Pharmaceuticals' GLOPERBA, an oral colchicine solution (0.6 mg/5 mL), received FDA approval under NDA 210942, with supplemental updates in 2021 and 2024.